Organization and Summary of Significant Accounting Policies (Details) |
9 Months Ended |
---|---|
Sep. 30, 2022
country
product
segment
| |
Organization And Summary Of Significant Policies [Line Items] | |
Number of countries with drug approval, excluding the u.s. | country | 62 |
Number of business segments | segment | 1 |
Resulting from discovery efforts | |
Organization And Summary Of Significant Policies [Line Items] | |
Number of products that entered in the commercial marketplace | 4 |
Products derived from other compounds | |
Organization And Summary Of Significant Policies [Line Items] | |
Number of products that entered in the commercial marketplace | 2 |